A double-blind, randomized, controlled study of the analgesic efficacy and tolerance of hydrocobone-5 MG/APAP 500 mg, hydrocodone 10mg/APAP 1000 mg and placebo in patients with pain following podiatric surgery.

被引：0
|
作者：
Brown, JD [1 ]
Reber, KR [1 ]
O'Callaghan, R [1 ]
Turpin, M [1 ]
机构：
[1] Res Foot & Ankle Inst, Salt Lake City, UT USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90594-7
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P64 / P64
页数：1
相关论文
共 50 条
  • [31] Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction:: Results of a multicenter, randomized, double-blind, placebo-controlled trial
    Porst, Hartmut
    Giuiano, Francois
    Glina, Sidney
    Ralph, David
    Casabe, Adolfo R.
    Elion-Mboussa, Albert
    Shenf, Wei
    Whitaker, J. Steve
    EUROPEAN UROLOGY, 2006, 50 (02) : 351 - 359
  • [32] A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS
    Krause, Richard
    Ameen, Vanessa
    Gordon, Susan H.
    West, Marquita
    Heath, Amy T.
    Perschy, Teresa
    Carter, Eric G.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (08): : 1709 - 1719
  • [33] Combination oxycodone 5 mg/Ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: A randomized, double-blind, placebo- and active-controlled parallel-group study
    Singla, N
    Pong, AP
    Newman, K
    CLINICAL THERAPEUTICS, 2005, 27 (01) : 45 - 57
  • [34] EVALUATION OF THE EFFICACY AND TOLERABILITY OF 2 DIFFERENT DOSAGES OF FENTICONAZOLE VAGINAL OVULES (600 MG AND 1000 MG) IN PATIENTS WITH VAGINAL TRICHOMONIASIS - A CONTROLLED, DOUBLE-BLIND, RANDOMIZED CLINICAL-TRIAL VERSUS PLACEBO
    GORLERO, F
    MACCHIAVELLO, S
    PELLEGATTA, L
    AIROLDI, ML
    GAFFURI, B
    PULICI, L
    DECECCO, L
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (05): : 510 - 518
  • [35] Randomised clinical trial: a multicentre, double-blind, placebo-controlled study on the efficacy and safety of rabeprazole 5 mg or 10 mg once daily in patients with non-erosive reflux disease
    Kinoshita, Y.
    Ashida, K.
    Hongo, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (02) : 213 - 224
  • [36] EFFICACY AND SAFETY OF OXYBUTYNIN TOPICAL GEL (84 MG OR 56 MG/DAY) IN PATIENTS WITH URGENCY AND/OR MIXED URINARY INCONTINENCE: RESULTS OF A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    Goldfischer, Evan
    Sand, Peter
    Peters-Gee, Jill
    JOURNAL OF UROLOGY, 2012, 187 (04): : E214 - E215
  • [37] Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of postoperative pain: A double-blind, placebo-and active-controlled parallel-group study
    Van Dyke, T
    Litkowski, LJ
    Kiersch, TA
    Zarringhalam, NM
    Zheng, HJ
    Newman, K
    CLINICAL THERAPEUTICS, 2004, 26 (12) : 2003 - 2014
  • [38] Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled study
    Nagao, Koichi
    Kimoto, Yasusuke
    Marumo, Ken
    Tsujimura, Akira
    Vail, G. Matthew
    Watts, Steven
    Ishii, Nobuhisa
    Kamidono, Sadao
    UROLOGY, 2006, 68 (04) : 845 - 851
  • [39] Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study
    Zuberbier, T.
    Oanta, A.
    Bogacka, E.
    Medina, I.
    Wesel, F.
    Uhl, P.
    Antepara, I.
    Jauregui, I.
    Valiente, R.
    ALLERGY, 2010, 65 (04) : 516 - 528
  • [40] A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia
    McEvoy, Joseph P.
    Daniel, David G.
    Carson, William H., Jr.
    McQuade, Robert D.
    Marcus, Ronald N.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2007, 41 (11) : 895 - 905
12345